A detailed history of Invenio Wealth Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Invenio Wealth Partners LLC holds 1,214 shares of LLY stock, worth $1.03 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
1,214
Previous 1,234 1.62%
Holding current value
$1.03 Million
Previous $960 Million 14.49%
% of portfolio
0.54%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $14,497 - $18,180
-20 Reduced 1.62%
1,214 $1.1 Billion
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $203,124 - $271,752
-343 Reduced 21.75%
1,234 $960 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $101,886 - $120,111
-194 Reduced 10.95%
1,577 $919 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $25,212 - $34,759
-58 Reduced 3.17%
1,771 $951 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $641,503 - $857,764
1,829 New
1,829 $858 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Invenio Wealth Partners LLC Portfolio

Follow Invenio Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenio Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invenio Wealth Partners LLC with notifications on news.